Katalin Mangó

CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients

K. Monostory, B. Merkely, M. Déri, 2021, Scientific Reports.

CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity

K. Monostory, F. Fekete, Katalin Mangó, 2022, Pharmaceutics.

CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function

K. Monostory, F. Fekete, Katalin Mangó, 2022, Scientific Reports.

Impact of genetic and non-genetic factors on hepatic CYP2C9 expression and activity in Hungarian subjects

K. Monostory, M. Déri, F. Fekete, 2021, Scientific Reports.

The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience.

K. Monostory, Katalin Mangó, Balázs Nemes, 2022, Transplantation proceedings.

Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

K. Farkas, T. Molnár, K. Monostory, 2023, Expert opinion on drug safety.

Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients

J. Moldvay, K. Monostory, D. Szüts, 2023, International journal of molecular sciences.

Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma

M. Garami, K. Monostory, T. Micsik, 2023, Scientific reports.